201 related articles for article (PubMed ID: 25065558)
1. oxLDL - the molecule linking hypercoagulability with the presence of cardiovascular disease in hemodialyzed uraemic patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Res; 2014 Sep; 134(3):711-6. PubMed ID: 25065558
[TBL] [Abstract][Full Text] [Related]
2. Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Haemost; 2009 Jul; 102(1):49-55. PubMed ID: 19572067
[TBL] [Abstract][Full Text] [Related]
3. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
[TBL] [Abstract][Full Text] [Related]
5. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 120(6):871-6. PubMed ID: 17331567
[TBL] [Abstract][Full Text] [Related]
7. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
8. Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis.
Wagner S; Apetrii M; Massy ZA; Kleber ME; Delgado GE; Scharnagel H; März W; Metzger M; Rossignol P; Jardine A; Holdaas H; Fellström B; Schmieder R; Stengel B; Zannad F;
Free Radic Res; 2017 Jan; 51(1):14-23. PubMed ID: 27667446
[TBL] [Abstract][Full Text] [Related]
9. Oxidized LDL to autoantibodies against oxLDL ratio - the new biomarker associated with carotid atherosclerosis and cardiovascular complications in dialyzed patients.
Pawlak K; Mysliwiec M; Pawlak D
Atherosclerosis; 2012 Sep; 224(1):252-7. PubMed ID: 22840691
[TBL] [Abstract][Full Text] [Related]
10. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
Pawlak K; Mysliwiec M; Pawlak D
Life Sci; 2013 Mar; 92(4-5):253-8. PubMed ID: 23295961
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
12. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
13. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
[TBL] [Abstract][Full Text] [Related]
14. Significance of the DNA-Histone Complex Level as a Predictor of Major Adverse Cardiovascular Events in Hemodialysis Patients: The Effect of Uremic Toxin on DNA-Histone Complex Formation.
Jeong JC; Kim JE; Gu JY; Yoo HJ; Ryu JW; Kim DK; Joo KW; Kim HK
Blood Purif; 2016; 41(1-3):64-71. PubMed ID: 26517236
[TBL] [Abstract][Full Text] [Related]
15. Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function.
Adams MJ; Irish AB; Watts GF; Oostryck R; Dogra GK
Thromb Res; 2008; 123(2):374-80. PubMed ID: 18486198
[TBL] [Abstract][Full Text] [Related]
16. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure.
Holvoet P; Donck J; Landeloos M; Brouwers E; Luijtens K; Arnout J; Lesaffre E; Vanrenterghem Y; Collen D
Thromb Haemost; 1996 Nov; 76(5):663-9. PubMed ID: 8950769
[TBL] [Abstract][Full Text] [Related]
17. Apelin: a potential link between inflammation and cardiovascular disease in end stage renal disease patients.
El-Shehaby AM; El-Khatib MM; Battah AA; Roshdy AR
Scand J Clin Lab Invest; 2010 Oct; 70(6):421-7. PubMed ID: 20645679
[TBL] [Abstract][Full Text] [Related]
18. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
Kirmizis D; Tsiandoulas A; Pangalou M; Koutoupa E; Rozi P; Protopappa M; Barboutis K
Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk factors in non-diabetic hemodialysis patients: a comparative study.
Tzanatos HA; Tseke PP; Pipili C; Retsa K; Skoutelis G; Grapsa E
Ren Fail; 2009; 31(2):91-7. PubMed ID: 19212904
[TBL] [Abstract][Full Text] [Related]
20. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
